News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Investor
Cynapsus Therapeutics (CYNAF) Announces Uplisting To The Toronto Stock Exchange’s Senior Equity Market 11/26/2014
Alkermes plc (ALKS)’ Corporate Presentation To Be Webcast At The NASDAQ OMX 31st Investor Program 11/26/2014
Immune Pharmaceuticals, Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 11/26/2014
University of New Hampshire Research Finds Growth In U.S. Angel Investor Market; Decrease In Deal Size 11/26/2014
Speculation Mounts That Pfizer (PFE) Will Up Bid For AstraZeneca PLC (AZN) As Cooling Off Period Ends 11/26/2014
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) To Host Annual Meeting Of Stockholders 11/26/2014
Ex-Retrophin (RTRX) CEO Sold Stock While Urging Investors To Buy 11/26/2014
NEMUS Bioscience Is Now Quoted On The OTC Bulletin Board Under The Ticker Symbol Of "NMUS" 11/26/2014
Medgenics, Inc. Prices Public Offering of Common Stock 11/26/2014
Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 11/26/2014
Analyst: First Quarter of 2015 Crucial to ProSensa Holding N.V. (RNA), BioMarin Pharmaceutical Inc. (BMRN) Deal 11/25/2014
Sarepta Therapeutics (SRPT) To Host Webcast And Conference Call For The Duchenne Muscular Dystrophy Community On December 2, 2014 11/25/2014
Investors Expect Record Year for Biotech Venture Capital 11/25/2014
Catalyst Pharmaceuticals (CPRX) CEO Outlines Biotech's 5 Phases Of Risk 11/25/2014
Becton, Dickinson and Company (BDX) And CareFusion Corporation Announce Expiration Of HSR Act Waiting Period In Proposed Transaction 11/25/2014
Perrigo Company plc Announces The Pricing Of Senior Notes Offering By Its Finance Subsidiary, Perrigo Finance plc 11/25/2014
Receptos (RCPT) Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares And Completion Of Underwritten Public Offering Of Common Stock 11/25/2014
Becton, Dickinson and Company (BDX) Board Declares Dividend 11/25/2014
Rockwell Medical (RMTI) Closes $58.5 Million Public Offering Of Common Stock 11/25/2014
Merck & Co. (MRK) Announces Increased Quarterly Dividend 11/25/2014
Conatus Pharmaceuticals Inc. To Present At Two December Investor Conferences 11/24/2014
CollabRx, Inc. Announces Receipt Of NASDAQ Notice Of Bid Price Deficiency 11/24/2014
Amicus Therapeutics, Inc. (FOLD) Announces Closing Of Underwritten Offering Of Common Stock And Full Exercise Of Over-Allotment Option 11/24/2014
Medgenics, Inc. Announces Public Offering of Common Stock 11/24/2014
BioMarin Pharmaceutical Inc. (BMRN), ProSensa Holding N.V. (RNA) Marriage Makes Sense for Investors If Regulatory Hurdles Can Be Overcome 11/24/2014
AVANIR Pharmaceuticals (AVNR) Making Strides With Alzheimer’s Drug, Says Analyst 11/24/2014
Perrigo Company plc Announces Proposed Public Offering Of Senior Notes Of Its Finance Subsidiary, Perrigo Finance plc 11/24/2014
Perrigo Company plc Announces Underwriters' Full Exercise Of Option To Purchase Ordinary Shares In Connection With The Equity Offering 11/24/2014
Marrone Bio Innovations, Inc Receives NASDAQ Notice Regarding Late Form 10-Q Filing 11/24/2014
OnCore Biopharma Announces Confidential Submission Of Draft Registration Statement For Initial Public Offering 11/24/2014
PlasmaTech Biopharmaceuticals, Inc. Announces Stock Ticker Symbol Change To PTBI 11/24/2014
Proteon Therapeutics, Inc. (PRTO) Announces The Closing Of Initial Public Offering And The Underwriters' Option To Purchase Additional Shares 11/24/2014
Tekmira (TKMR) Provides Key Highlights Of Analyst And Investor Day In New York 11/24/2014
Bayer AG (BAYZF) To Use IPO Funds To Cut Debt And Buy Consumer Drugs 11/24/2014
EXCLUSIVE: Ackman Says “Biggest Mistake” In Allergan (AGN) Bid Was Tender Offer 11/21/2014
Solid Lymphoma Data Points To Larger Potential For Epizyme (EPZM), Says Citi 11/21/2014
Cytori Therapeutics, Inc. (CYTX) To Provide Corporate Update And Investor Presentation On December 4 Through A Live, Interactive Webcast 11/21/2014
Perrigo Company Plc Announces The Pricing Of Its Offering Of Ordinary Shares 11/21/2014
Lexicon Pharmaceuticals, Inc. (LXRX) Announces Pricing Of Common Stock Offering 11/21/2014
Agilent Technologies Inc. (A) Announces Cash Dividend Of 10 Cents Per Share 11/21/2014
Neovacs SA Secures A New Equity Line Financing With Kepler Cheuvreux 11/21/2014
ZS Pharma (ZSPH) Hosts And Webcasts Investor Event 11/20/2014
StemCells Inc. (STEM)To Host Inaugural Investor And Analyst Event In New York 11/20/2014
Matinas BioPharma To Present At Two Investor Conferences In Early December 11/20/2014
MYOS (MYOS) Announces $1.81 Million Registered Direct Offering 11/20/2014
Cowen: Acorda Therapeutics (ACOR) Not Worried About Civitas Therapeutics' New Parkinson's Drug 11/20/2014
Rockwell Medical (RMTI) Prices $58.5 Million Public Offering Of Common Stock 11/20/2014
Perrigo Company plc Announces Proposed Public Offering Of Ordinary Shares 11/20/2014
Organovo Holdings, Inc. To Provide Corporate Update And Investor Presentation In A Live, Interactive Webcast On December 4 11/20/2014
Immune Pharmaceuticals, Inc. Announces Pricing Of Public Offering Of Common Stock And Warrants To Purchase Common Stock 11/20/2014
Cipher Pharmaceuticals (DND.TO) To Commence Trading On The NASDAQ Global Market 11/20/2014
Valeant (VRX) Announces New $2 Billion Securities Repurchase Program 11/20/2014
Aequus Pharmaceuticals Closes $4.2 Million Private Placement Financing 11/20/2014
LentiGlobin Looks Promising On Sickle Cell For bluebird bio (BLUE), Says Analyst 11/19/2014
Receptos (RCPT) Announces Pricing Of Underwritten Public Offering Of Common Stock 11/19/2014
Amicus Therapeutics, Inc. (FOLD) Prices Underwritten Offering Of Common Stock 11/19/2014
SYGNIS Pharma AG Release: GBC Research Reiterates “BUY” Recommendation For SYGNIS Shares With Price Target Of €4.05 11/19/2014
Immune Pharmaceuticals, Inc. Announces Proposed Public Offering Of Common Stock And Warrants To Purchase Common Stock 11/19/2014
Lexicon Pharmaceuticals, Inc. (LXRX) Announces Proposed Convertible Senior Notes Offering 11/19/2014
Amicus Therapeutics, Inc. (FOLD) Announces Public Offering Of Common Stock 11/19/2014
Covidien plc (COV) Release: Announcement Under Irish Takeover Rules Relevant Securities In Issue – November 19, 2014 11/19/2014
Daxor Corporation (DXR) Announces Payment Of A Dividend 11/19/2014
Zoetis (ZTS) Announces Authorization Of $500 Million Share Repurchase Program 11/18/2014
Paulson Opens New Stake In AbbVie (ABBV), Nearly Triples Shire Shares 11/18/2014
Rockwell Medical (RMTI) Announces $55 Million Proposed Public Offering Of Common Stock 11/18/2014
Horizon Pharma plc.  (HZNP) Announces Pricing Of Secondary Offering Of Ordinary Shares By Selling Shareholders 11/18/2014
PRA Health Sciences Announces Successful Closing Of Its Initial Public Offering 11/18/2014
Cowen: Achaogen (AKAO)’s New Antibiotic Could Be Key to Solving Types of Drug Resistance 11/17/2014
Best Value In Biotech? Actavis (ACT), Says UBS 11/17/2014
Forward Pharma (FWP) Announces Closing Of Partial Exercise Of Over-Allotment Option 11/17/2014
Arno Therapeutics Reports Third Quarter 2014 Financial And Business Update 11/17/2014
Alcobra (ADHD) Announces Third Quarter Financial Results And Provides Corporate Update 11/17/2014
Nephros Inc. (NEP) Reports Third Quarter 2014 Financial Results And Announces Launch Of Rights Offering 11/17/2014
Actavis (ACT) Successfully Completes Durata Therapeutics, Inc.  (DRTX) Tender Offer 11/17/2014
ISI: Merck & Co. (MRK)’s Zetia News The Rising Tide To Lift All LDL Boats 11/17/2014
Hemispherx Biopharma (HEB) Reports on Annual Stockholder Meeting 11/17/2014
Bacterin International, Inc. Receives Delisting Notice From NYSE MKT 11/17/2014
If Investors Like Merck & Co. (MRK)'s Zetia Results, They Will Love Esperion Therapeutics, Inc. (ESPR)’s, Says Citi 11/17/2014
Amarantus To Host Business Update Conference Call On November 18, 2014 11/17/2014
Receptos (RCPT) Announces Proposed Underwritten Public Offering Of Common Stock 11/17/2014
PTC Therapeutics, Inc. (PTCT) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 11/17/2014
Can-Fite BioPharma (CFBI) Announces Special General Meeting Of Shareholders To Elect External Director 11/17/2014
FibroGen, Inc. (FGEN) Announces Full Exercise Of Greenshoe Option 11/17/2014
NanoViricides, Inc. (NNVC.PK) Files Quarterly Report - Reports Further Improved Strong Cash Position Sufficient For Clinical Trials Of Its First Two Drug Candidates 11/17/2014
Zoetis (ZTS) Adopts One-Year Shareholder Rights Plan 11/17/2014
Akebia Therapeutics, Inc. (AKBA) President And Chief Executive Officer Establishes Stock Purchase Plan 11/17/2014
GTx, Inc. (GTXI) Announces Closing Of $43.4 Private Placement 11/17/2014
Biotech Investors Bullish On Large Cap; Citi Adds Vertex Pharmaceuticals (MA) (VRTX), BioMarin Pharmaceutical Inc. (BMRN) and Tesaro, Inc. (TSRO) To Most Preferred 11/14/2014
Patent Fight Between Amgen (AMGN) And Sanofi (SAN.PA)/Regeneron (REGN) Getting Murkier, Says Analyst 11/14/2014
With Promising New Gout Treatment In Its Pipeline, 2015 Will Be Big Year For CymaBay Therapeutics 11/14/2014
Trillium Therapeutics Inc. Provides Corporate Update And Announces Reverse Stock Split For NASDAQ Listing 11/14/2014
Celator Pharmaceuticals, Inc. Announces Business Update And Third Quarter 2014 Financial Results 11/14/2014
Pfenex Inc. (PFNX) Reports Third Quarter 2014 Results And Provides Business Update 11/14/2014
PTC Therapeutics, Inc. (PTCT) To Webcast Upcoming Science Day And Investor Conferences 11/14/2014
Horizon Pharma plc.  (HZNP) Announces Proposed Secondary Offering Of Ordinary Shares By Selling Shareholders 11/14/2014
Easton Pharmaceuticals (OP: EAPH) Engages Accredited Independent Auditor To Commence An Audit Of Company's Financial Statement Or Years Ending 2013 And 2014 11/14/2014
Tokai Pharmaceuticals (TKAI) To Ring The Nasdaq Stock Market Opening Bell 11/14/2014
DS Healthcare Group Issues Letter To Shareholders 11/14/2014
Tekla Life Sciences Investors Declares Stock Distribution 11/14/2014
Analyst: Amgen (AMGN)’s Psoriasis Drug Is Superior To Stelara And Sales Will Reflect That 11/13/2014
Gilead Sciences, Inc. (GILD) Prices $4 Billion Of Senior Unsecured Notes 11/13/2014
Aegerion Pharmaceuticals, Inc. (AEGR) Grants Stock Options Under Inducement Program 11/13/2014
Coherus Biosciences Announces Closing Of Initial Public Offering And Exercise Of Underwriters' Option To Purchase Additional Shares 11/13/2014
PRA Health Sciences Announces Pricing Of Its Initial Public Offering 11/13/2014
Roche Holding AG (RHHBF.PK) Announces Pricing Of Its Debt Tender Offer 11/13/2014
Amgen (AMGN) To Webcast Investor Call At Upcoming American Heart Association Scientific Sessions 11/13/2014
Mast Therapeutics (MSTX) Announces Closing Of Underwritten Public Offering 11/13/2014
Roche (RHHBY) Announces Early Tender Results Of Its Debt Tender Offer 11/13/2014
Bioniche Life Sciences Inc. (BNC) Announces Results Of Annual General Meeting Of Shareholders 11/13/2014
Dow Outlines Next Layer Of Strategic Actions At Investor Forum 2014 11/13/2014
Cellectis (ALCLS) Received Proceeds of €13 Million Through The Exercise Of Warrants 11/13/2014
Regeneron (REGN), Sanofi (SAN.PA) Asthma Drug A Potential Blockbuster For Allergies, Says Analyst 11/12/2014
Isis Pharmaceuticals, Inc. (ISIS) Prices Offering Of $425 Million Of 1.00% Convertible Senior Notes 11/12/2014
Galmed Pharmaceuticals Provides Business Update And Reports Year-To-Date 2014 Financial Results 11/12/2014
Bioniche Life Sciences Inc. (BNC) Reports MCNA Update & First Quarter Results 11/12/2014
Affymetrix (Santa Clara, California) (AFFX) Announces Webcast Of Investor Day 2014 On Monday November 17, 2014 11/12/2014
Extraordinary General Meeting Held In Nordic Nanovector ASA 11/12/2014
Nevro Corp Announces Full Exercise Of Over-Allotment Option And Closing Of Initial Public Offering 11/12/2014
PTC To Ring The Nasdaq Stock Market Closing Bell 11/12/2014
Allergan Inc. (AGN) Board Of Directors Announces Approval Of Amendments To Company’s Bylaws 11/12/2014
Citi: Esperion Therapeutics, Inc. (ESPR) Will See Cancer Drug Data By End Of Year 11/11/2014
Gilead Sciences, Inc. (GILD) Poised To Be One Of The Most Remarkable Growth Stories In Biotech, Says Analyst 11/11/2014
ULURU Inc. Announces Conference Call To Discuss Financial Results For The Third Quarter Ended September 30, 2014 And To Provide A Business Update 11/11/2014
Isis Pharmaceuticals, Inc. (ISIS) Announces Proposed Offering Of $425 Million of Convertible Senior Notes 11/11/2014
Daiichi Sankyo, Inc. (4568.t) And Ambit Biosciences Announce Results Of Tender Offer 11/11/2014
Acasti Pharma Receives NASDAQ Notification Regarding Minimum Bid Requirements 11/11/2014
WuXi PharmaTech Co., Ltd. Announces Shareholder Resolutions Adopted At 2014 Annual General Meeting 11/11/2014
EPIRUS Biopharmaceuticals Reports Third Quarter Results And Provides Corporate Update 11/11/2014
Ophthotech Corporation (OPHT) Provides Business Update And Reports Third Quarter 2014 Financial Results 11/11/2014
Analyst: Celgene (CELG)’s Drug Pipeline Will Be The Gift That Keeps On Giving 11/10/2014
INC Research, Inc. To Ring The Nasdaq Stock Market Opening Bell In Celebration Of IPO 11/10/2014
Mirati Therapeutics  (MRTX) Reports Third Quarter 2014 Financial Results And Provides Business Update 11/10/2014
Dynavax Technologies Corporation (DVAX) Announces One-for-Ten Reverse Stock Split 11/10/2014
Centene Corporation To Provide 2015 Financial Guidance And Host Investor Meeting In NYC On December 12, 2014 11/10/2014
DelMar Pharmaceuticals Announces September 30, 2014 Results And Provides Corporate Update 11/10/2014
AB Science (AB.PA): Masitinib In Mastocytosis - Summary Of Web Conference 11/10/2014
GTX Corp Provides Corporate Update And Reports Third Quarter 2014 Financial Results 11/10/2014
Citi: Agios Pharmaceuticals (AGIO)’s Experimental Cancer Drug Could Provide Major Upside 11/10/2014
Bristol-Myers Squibb Company (BMY), Merck & Co. (MRK) Competing Hodgkin’s Drugs Look Comparable, Says Analyst 11/7/2014
GENFIT Corp. (ALGFT) To Participate In Three Upcoming Investor Conferences 11/7/2014
Capricor Therapeutics, Inc. To Hold Duchenne Muscular Dystrophy Data Presentation Call On November 18, 2014 At 9:30 A.M. ET 11/7/2014
TherapeuticsMD, Inc.  (TXMD) Looking At Lower Cash Burn, Higher Upside From Promising HRT Therapies: Cowen 11/7/2014
CTI BioPharma Prices Underwritten Public Offering Of $35 Million Of Convertible Preferred Stock 11/7/2014
Coronado Biosciences (CNDO) Raises $3.5 Million Through The Private Placement Of Restricted Common Stock 11/7/2014
CTI BioPharma Announces Proposed Public Offering Of Convertible Preferred Stock 11/7/2014
CytoSorbents, Inc. Issues Shareholder Update Letter On Consent Solicitation Statement And Up-Listing Plans 11/7/2014
Pharmacyclics, Inc. (PCYC), AstraZeneca PLC (AZN) Partnership Holds Tumor Promise: Citi 11/6/2014
BioDelivery Sciences International (BDSI) Provides Business Review And Update In Conjunction With Filing Of Third Quarter 2014 Financials 11/6/2014
Nevro Corp Announces Pricing of Initial Public Offering 11/6/2014
Chimerix, Inc. (CMRX) Announces Completion Of Public Offering Of Common Stock And Exercise In Full Of Option To Purchase Additional Shares Of Common Stock 11/6/2014
ADMA Biologics, Inc. Approved For Trading On NASDAQ 11/6/2014
Senomyx, Inc. (SNMX) Announces Corporate Update And Third Quarter 2014 Financial Results 11/6/2014
PTC Therapeutics, Inc. (PTCT) Reports Third Quarter Financial Results And Provides Corporate Update 11/6/2014
Pfenex Inc. (PFNX) To Report Third Quarter 2014 Results And Provide Business Update On Thursday, November 13, 2014 11/6/2014
Mast Therapeutics (MSTX) Announces Pricing Of Underwritten Public Offering 11/6/2014
Coherus Biosciences Prices Initial Public Offering Of $85 Million Of Common Stock 11/6/2014
Sangui BioTech International Inc. (SGBI) Officially Approved As Trading On OTCQB 11/6/2014
Thermo Fisher Scientific (TMO) Announces Offering Of Dollar-Denominated Senior Notes 11/6/2014
Meda AB (MEDA-A.ST) Extraordinary General Meeting Bulletin 11/6/2014
Tekmira (TKMR) To Host Analyst Day On November 21 In New York City 11/6/2014
Mast Therapeutics (MSTX) Announces Underwritten Public Offering 11/5/2014
Quintiles Transnational Corp. Announces Launch of Secondary Public Offering And Repurchase Of Common Stock 11/5/2014
Rand Capital Increases Net Asset Value To $4.47, One New Investment In Crashmob, Inc., Two Follow-On Investments, Sale Of QuaDPharma And Continued Stock Repurchase Plan 11/5/2014
Under Immense Pressure, Amgen (AMGN) Outlines Strategy 11/5/2014
Kythera Biopharmaceuticals (KYTH) Grants Stock Options Under Inducement Program 11/5/2014
Oncolytics Biotech Inc. (ONC.TO) Announces Receipt Of Nasdaq Notice Of Deficiency 11/5/2014
Galmed Pharmaceuticals To Host Key Opinion Leader Meeting And Webcast On November 7, 2014 In New York City 11/5/2014
Karolinska Development AB Secures Funding From CP Group, A Leading Asian Life Science Investor, And Initiates Preparation For A Convertible Bond Issue 11/5/2014
Update to The Medicines Company (MDCO) Investor & Analyst Day On November 5 11/5/2014
Merck Animal Health Provides Update On Zilmax Five-Step Plan, Announces Next Steps 11/5/2014
Regulus Therapeutics, Inc. (RGLS) Announces Closing of Public Offering Of $103.5M Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares 11/4/2014
NeuroDerm Announces Launch Of Initial Public Offering 11/4/2014
ULURU Inc. Provides Business Update 11/4/2014
Nordic Nanovector: Extraordinary General Meeting On 12 November 2014 11/4/2014
Sarepta Therapeutics (SRPT) To Present Company Overview At Upcoming Conferences 11/4/2014
StemCells Inc. (STEM) To Host Inaugural Investor And Analyst Event In New York 11/4/2014
Oxford Immunotec Limited (OXFD) To Host Technology Day 11/4/2014
AtheroNova Inc. (AHRO.OB) Announces Closing Of Public Offering Of Common Stock And Warrants 11/3/2014
VWR, Inc. Announces Exercise Of Over-Allotment Option 11/3/2014
Sigma-Aldrich Corporation (SIAL) Announces Filing Of Definitive Proxy Statement And Date Of Special Meeting Of Stockholders 11/3/2014
TetraLogic Pharmaceuticals (TLOG) To Host Investor Forum On November 10, 2014 11/3/2014
BioMarin Pharmaceutical Inc. (BMRN),Incyte Corporation (INCY) Part Of Rally As Biotech Sector Booms, Says Cowen 11/3/2014
Cellceutix (CTIX)'s New Chief Operating Officer Dr. James Alexander Addresses Shareholders 11/3/2014
Change In The Number Of Shares And Votes In Meda AB (MEDA-A.ST) 10/31/2014
AbbVie (ABBV) Might Go Shopping Again Despite Shire Breakup, Say Company Execs 10/31/2014
Citi: Gilead Sciences, Inc. (GILD) Sees Blockbuster First Weeks Of Harvoni Launch 10/31/2014
Chimerix, Inc. (CMRX) Prices Public Offering Of Common Stock 10/31/2014
Dyadic International, Inc. Extends All Convertible Debt Maturity Dates 10/31/2014
Cellectis (ALCLS): Event Report: Individual Shareholders’ Meeting Held On October 23, 2014 10/31/2014
The Medicines Company (MDCO) To Webcast Investor & Analyst Day On November 5 10/31/2014
Amgen (AMGN), Sandoz, Inc. Biosimilar War Could Provide Playbook, Says Analyst 10/31/2014
Chimerix, Inc. (CMRX) Announces Commencement Of Public Offering Of Common Stock 10/30/2014
Cowen: Amgen (AMGN)’s Plans Are “Music To Our Ears" 10/30/2014
Synergy Pharmaceuticals Announces Full Exercise Of Over-Allotment Option 10/30/2014
Roche Holdings, Inc. Announces Debt Tender Offer 10/30/2014
Ambit Biosciences Announces Expiration Of Hart-Scott-Rodino Waiting Period 10/30/2014
Neptune Technologies & Bioressources Inc. Receives TSX Approval For Normal Course Issuer Bid 10/30/2014
Ebola Epidemic Unlikely But Not Impossible, Says Immunovaccine Inc. CEO 10/29/2014
Synergy Pharmaceuticals Announces Private Offering Of Convertible Senior Notes 10/29/2014
Corbus Pharmaceuticals, Inc. Commences Trading On OTCQB Under Ticker Symbol CRBP 10/29/2014



//-->